Ubs Group Ag Protalix Bio Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 292 shares of PLX stock, worth $662. This represents 0.0% of its overall portfolio holdings.

Number of Shares

292

Previous 307 4.89%

Holding current value

$662

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.9 - $1.17 $13 - $17	-15 Reduced 4.89%	292 $0
Q2 2024 Aug 13, 2024	SELL	$1.1 - $1.32 $74,413 - $89,296	-67,649 Reduced 99.55%	307 $0
Q1 2024 May 13, 2024	SELL	$1.22 - $1.82 $8,249 - $12,306	-6,762 Reduced 9.05%	67,956 $85,000
Q4 2023 Feb 09, 2024	BUY	$1.34 - $1.85 $50,461 - $69,667	37,658 Added 101.61%	74,718 $132,000
Q3 2023 Nov 09, 2023	SELL	$1.49 - $2.02 $22,320 - $30,259	-14,980 Reduced 28.79%	37,060 $61,000
Q2 2023 Aug 11, 2023	BUY	$2.0 - $3.36 $94,698 - $159,092	47,349 Added 1009.36%	52,040 $104,000
Q1 2023 May 12, 2023	BUY	$1.37 - $2.16 $6,262 - $9,873	4,571 Added 3809.17%	4,691 $9,000
Q4 2022 Feb 08, 2023	SELL	$1.0 - $1.37 $10,998 - $15,067	-10,998 Reduced 98.92%	120 $0
Q3 2022 Nov 10, 2022	BUY	$1.03 - $1.24 $11,327 - $13,637	10,998 Added 9165.0%	11,118 $11,000
Q4 2021 Feb 14, 2022	SELL	$0.81 - $1.33 $1,777 - $2,918	-2,194 Reduced 94.81%	120 $0
Q3 2021 Nov 15, 2021	BUY	$1.31 - $1.87 $509 - $727	389 Added 20.21%	2,314 $3,000
Q2 2021 Aug 13, 2021	SELL	$1.86 - $6.22 $502 - $1,679	-270 Reduced 12.3%	1,925 $3,000
Q1 2021 May 12, 2021	BUY	$3.58 - $6.45 $3,572 - $6,437	998 Added 83.38%	2,195 $10,000
Q4 2020 Feb 11, 2021	SELL	$3.15 - $3.98 $10,442 - $13,193	-3,315 Reduced 73.47%	1,197 $5,000
Q3 2020 Nov 12, 2020	BUY	$3.37 - $3.93 $2,894 - $3,375	859 Added 23.51%	4,512 $17,000
Q2 2020 Jul 31, 2020	BUY	$2.19 - $4.5 $7,608 - $15,633	3,474 Added 1940.78%	3,653 $14,000
Q1 2020 May 01, 2020	BUY	$2.1 - $4.61 $270 - $594	129 Added 258.0%	179 $0
Q4 2019 Feb 14, 2020	BUY	$1.8 - $3.28 $90 - $164	50 New	50 $0

Others Institutions Holding PLX

# of Institutions

Shares Held

3.58M

Call Options Held

61.1K

Put Options Held

36.2K

View Full List

About Protalix BioTherapeutics, Inc.

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $113M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

More about PLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account